| | 
Part, Chapter, Paragraph
1 IV, 11.Acr | Positron Emission Tomography~PHI~Private health insurance~
2 IV, 11. 1. 6| Private health insurance (PHI) is associated with much
3 IV, 11. 1. 6| administrative costs of PHI in Germany, Luxembourg,
4 IV, 11. 1. 6| administration associated with PHI could largely be avoided
5 IV, 11. 6. 2| payment, as the role of PHI remains limited in most
6 IV, 11. 6. 2| Private health insurance (PHI) plays a relatively minor
7 IV, 11. 6. 2| private health insurance (PHI) and out-of-pocket payments,
8 IV, 11. 6. 2| The agents collecting PHI premiums can be independent,
9 IV, 11. 6. 2| in countries that have a PHI market) or private not-for-profit
10 IV, 11. 6. 2| Mossialos and Dixon, 2002).~ ~PHI can be classified as substitutive,
11 IV, 11. 6. 2| services.~ ~Since 2000, PHI has grown as a proportion
12 IV, 11. 6. 2| expenditure. Spending on PHI as a proportion of private
13 IV, 11. 6. 2| Austria, Spain and the UK. PHI constitutes a much higher
14 IV, 11. 6. 2| Member States permitting PHI markets, PHI remains relatively
15 IV, 11. 6. 2| permitting PHI markets, PHI remains relatively undeveloped
16 IV, 11. 6. 2| of funding derives from PHI; here PHI is complementary
17 IV, 11. 6. 2| funding derives from PHI; here PHI is complementary in covering
18 IV, 11. 6. 2| tax incentives to purchase PHI are in place, though this
19 IV, 11. 6. 2| tax incentives to purchase PHI in some European countries,
20 IV, 11. 6. 2| in stimulating demand for PHI. There are no tax incentives
21 IV, 11. 6. 2| to purchase any kind of PHI in Denmark, Finland, Spain
22 IV, 11. 6. 2| for employers purchasing PHI for their employees in Finland,
23 IV, 11. 6. 2| hand, tax disincentives for PHI can be seen in some countries
24 IV, 11. 6. 2| impact of a tax subsidy on PHI contributions should be
|
|
| |
